Novavax Inc. (NVAX)
NASDAQ · Healthcare
Novavax Inc. Total Liabilities 2010–2025
Novavax Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Novavax Inc. total liabilities as of December 31, 2025: 1.30B, a 40.29% decrease year-over-year.
- Novavax Inc. total liabilities for 2025 were 1.30B, a 40.29% decrease from 2024.
- Novavax Inc. total liabilities for 2024 were 2.18B, a 13.13% decrease from 2023.
- Novavax Inc. total liabilities for 2023 were 2.51B, a 13.08% decrease from 2022.
- Novavax Inc. total liabilities for 2022 were 2.89B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Novavax Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $1,304 |
| 2024 | $2,184 |
| 2023 | $2,514 |
| 2022 | $2,893 |
| 2021 | $2,928 |
| 2020 | $955 |
| 2019 | $359 |
| 2018 | $376 |
| 2017 | $404 |
| 2016 | $400 |
| 2015 | $93 |
| 2014 | $46 |
| 2013 | $32 |
| 2012 | $22 |
| 2011 | $13 |
Novavax Inc. Total Liabilities — FAQ
Novavax Inc. (NVAX) total liabilities over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NVAX's total liabilities history?
The chart and table above show Novavax Inc.'s total liabilities by year and by quarter, including the growth rate.